Infectious diseases are the most common cause of death worldwide. In Germany, more than 40,000 people died of the consequences of an infection in 2006. Since the percentage of resistant pathogens has risen in recent years, and a further increase cannot be ruled out, a targeted approach is needed to reduce antimicrobial resistance and strengthen preventive measures at the local, regional and national level. The containment of antimicrobial resistance necessitates a comprehensive examination of the problem, since antimicrobial resistance occurs both in the field of human medicine and in veterinary medicine. Consequently, an Antimicrobial Resistance Strategy for Germany was developed in 2011 (http://www.bmg.bund.de/fileadmin/dateien/Publikationen/Gesundheit/Sonstiges/DART_-_German_Antimicrobial_Resistance_Strategy.pdf)
Thus, besides the national engagement in research in this field and the implementation of a German Antibiotic Resistance Strategy, coordinating and strengthening the European research efforts is a particular concern.
Germany represented by the Federal Ministry of Education and Research (BMBF) is partner in the development and implementation of JPI-AMR.